01 Almirall at a glance:
2024, a year of visionary progress
Bridging vision and innovation to ensure life-changing dermatology solutions.
KEY DATA & FIGURES OF 2024
2024 was a strong year for Almirall: we delivered significant business growth and progressed our innovative pipeline. Our strategic focus on medical dermatology has created a unique position for the company that has enabled us to enter an era of sustained growth and profitability. The significant positive impact Almirall has on patients and the medical community is set to grow further as we progress our business strategy and achieve our ambition as leader in medical dermatology.
€192.6 MM
EBITDA
€985.7 MM
NET SALES
+10.2% YoY
NET SALES GROWTH
NET SALES IN DERMATOLOGY
€548.1 MM
56% of total sales
+17.8% YoY
growth
NET SALES IN DERMATOLOGY BY GEOGRAPHY
EUROPE
88%
US
10%
RoW
2%
COLLABORATION & INNOVATION
Continuing to push the boundaries of science and innovation through collaboration, our efforts are rooted in our commitment to advancing science and product development to shape the future of medical dermatology. Becoming a preferred partner for dermatologists supports us in our ambition and our ability to help more patients to realize their hopes and dreams for a healthy life.
12.6%
INVESTMENT OF NET SALES IN R&D
13
CURRENT PIPELINE PROJECTS
22
CURRENT R&D PARTNERSHIPS
ALMIRALL’S GLOBAL PRESENCE
total employees
2,026
country presence
+100
countries with direct presence
19
In 2024, we continued to grow our global presence advancing ground-breaking treatments in dermatology and giving more patients access to more products.
In 2024, we continued to grow our global presence advancing ground-breaking treatments in dermatology and giving more patients access to more products.
Patients
at the core
As part of our ongoing commitment to improve the lives of people with skin conditions, we continue to prioritize innovation and patient access, from our efforts in patient-centred programmes to development and research.
640,000
Patients treated with our key dermatology products
145
NUMBERS OF PRODUCTS
55
DERMATOLOGY PRODUCTS
Major Milestones in 2024
A year of groundbreaking achievements
Celebrating 80 years of history and innovation.
80 YEARS
of science, research, and innovation
Our dedication to healthcare innovation and delivering impactful products to patients in need began 80 years ago. In 2024, we celebrated what we have achieved in over eight decades and our future as we continue to build our story of supporting patients and the medical community.
Today, we are more than 2,000 people with a portfolio of over 140 products in more than 100 countries, over 50 different products in medical dermatology alone. Thanks to our strong track record of creating close collaborations and meaningful partnerships, we are covering 60% of office dermatologists and 90% of hospital dermatologists across Europe. Our goals go beyond clinical endpoints, as we strive to give patients their lives back through deeper understanding of their disease burden and continued research and innovation to deliver meaningful solutions.
OUR LONG-TERM STRATEGY
Our ambition is built on 4 pillars
Partnering with dermatologists
Transforming patients’ lives
Growing and innovating business
Making a mark in sustainability and social impact
Our business strategy builds on our unique company heritage, structure, and our focus on medical dermatology and innovation. As we have entered an era of sustained growth and profitability, we will continue to build our business based on our strategy phases.
